[Form 4] NEOGEN CORP Insider Trading Activity
Neogen Corp director Ronald D. Green had 2,071 restricted stock units (RSUs) vest on 10/07/2025 and those RSUs were settled into an equal number of shares of common stock at an effective price of $5.63 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Neogen Corp director Ronald D. Green had 2,071 restricted stock units (RSUs) vest on 10/07/2025 and those RSUs were settled into an equal number of shares of common stock at an effective price of $5.63 per share. After the settlement, Mr. Green directly owned 14,852 shares. The Form 4 was signed by an attorney-in-fact on 10/09/2025. The filing records a routine equity compensation settlement rather than an open-market purchase or sale.
Insights
Director RSU vesting shows alignment with shareholders through equity compensation.
The reported transaction documents the vesting and settlement of 2,071 RSUs into common shares on 10/07/2025, increasing the director's direct holdings to 14,852 shares. This is a standard compensation event where the RSUs convert to shares at the stated value.
Key dependencies include the company's equity award schedule and any trading-window or blackout restrictions that govern when shares can be sold. Near-term visibility: this is a settled award with no further conversion dates disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,071 | $5.63 | $12K |
| Exercise | Common Stock | 2,071 | $5.63 | $12K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Neogen (NEOG) report on Form 4 dated 10/07/2025?
At what price were the RSUs settled for Neogen (NEOG)?
Was the Form 4 filed jointly or by one reporting person?
Does the Form 4 indicate any derivative transactions or future exercisable awards?
AI-generated analysis. How Rhea-AI works. Not financial advice.